What's new

2024 annual report of the European Medicines Agency

2024 annual report of the European Medicines Agency

Jun 10, 2025 - 13:45
 0
2024 annual report of the European Medicines Agency
Read More

Tags:

Previous Article

Annex 10 - 2024 annual report of the European Medicines Agency – CHMP opinions o...

Next Article

Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, ...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Benlysta, belimumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0109/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 11, 2025  0

Human medicines European public assessment report (EPAR): Apexelsin, paclitaxel, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 10, 2025  0

Annex to 27-30 January 2025 CHMP Minutes

May 28, 2025  0